About
As President and CEO, Joseph is focused on optimizing the translational value of InterVivo's services to facilitate the development and approval of novel drugs. Joseph continues to be closely involved in projects utilizing, characterizing and developing the aged dog as a natural model of age-related human diseases. Joseph is a strong proponent for the use of validated natural and/or translational animal models in drug discovery. His scientific background includes graduate training in pharmacology at the University of Toronto, more than 25 refereed publications and several invited presentations, which exemplifies his continued passion for scientific innovation and expertise in natural aged canine models of human disease. Joseph directly supports developing of local biotech talent and companies and has co-founded and held executive level positions in several Ontario-based Contract Research and Life Science companies helping to build their global presence and success.
Position in the VCSift Database
- • 1 investors hold the Co-Founder, Director, and Chief Scientific Officer role in VCSift. Joseph Araujo is one of them.
- • 2,014 investors are based in Toronto, Ontario, Canada.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Toronto, Canada
Contact Information
Find more investors like Joseph
Search Investors